WASHINGTON, DC – Energy and Commerce Committee Chairman Greg Walden (R-OR) and Health Subcommittee Chairman Michael C. Burgess, M.D. (R-TX) today issued the following statement after President Trump signed into law S. 292, the Childhood Cancer STAR Act.
The bipartisan bill will help advance both research on and treatments for pediatric cancer. In addition, S. 292 will also bolster the surveillance of pediatric cancer, and require the National Cancer Advisory Board to have at least one pediatric oncology expert on its board.
“Today is a day for hope. From the youngest patients battling cancer to those who care for them, the Childhood Cancer STAR Act is a win that will change lives,” said Energy and Commerce Committee Chairman Greg Walden (R-OR) and #SubHealth Chairman Michael C. Burgess, M.D. (R-TX). “Building off the monumental 21st Century Cures Act, this law will continue to bolster our research and treatment efforts, as well as ensure we continue to take care of pediatric cancer survivors. It’s a big day for our youngest fighters, and it’s one that can change the course of how we research and treat this terrible disease.”
S. 292 passed the House of Representatives on May 22, 2018, by voice vote, and the Senate on March 22, 2018, by unanimous consent.